MEDICINOVA INC (MNOV) Stock Analyst Ratings
USA - NASDAQ:MNOV - US58468P2065 - Common Stock
1.22 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 83% to MNOV. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.14. This target is 485.25% above the current price.
MNOV was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about MNOV.
In the previous month the buy percentage consensus was at a similar level.
MNOV was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-22 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-27 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-07-24 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-16 | B. Riley Securities | Maintains | Buy -> Buy |
| 2025-04-09 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-14 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-02-21 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-12-06 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-12-02 | D. Boral Capital | Initiate | Buy |
| 2021-03-10 | Maxim Group | Initiate | Buy |
MEDICINOVA INC / MNOV FAQ
What is the average price target for MEDICINOVA INC (MNOV) stock?
8 analysts have analysed MNOV and the average price target is 7.14 USD. This implies a price increase of 485.25% is expected in the next year compared to the current price of 1.22.
Can you provide the consensus rating for MEDICINOVA INC stock?
The consensus rating for MEDICINOVA INC (MNOV) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover MEDICINOVA INC (MNOV) stock?
The number of analysts covering MEDICINOVA INC (MNOV) is 8.